PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
StageZero Life Sciences Ltd. (SZLS.TO)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

CA8525403017

CUSIP

852540301

Sector

Healthcare

Highlights

Market Cap

CA$4.94M

EPS (TTM)

-CA$0.16

Total Revenue (TTM)

CA$1.41M

Gross Profit (TTM)

CA$238.76K

EBITDA (TTM)

-CA$850.89K

Year Range

CA$0.04 - CA$0.06

Target Price

CA$1.25

Short %

0.23%

Short Ratio

0.50

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of CA$10,000 in StageZero Life Sciences Ltd., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%5.00%10.00%15.00%SeptemberOctoberNovemberDecember2025February0
15.32%
SZLS.TO (StageZero Life Sciences Ltd.)
Benchmark (^GSPC)

Returns By Period

StageZero Life Sciences Ltd. had a return of 0.00% year-to-date (YTD) and -0.00% in the last 12 months. Over the past 10 years, StageZero Life Sciences Ltd. had an annualized return of -40.65%, while the S&P 500 had an annualized return of 11.26%, indicating that StageZero Life Sciences Ltd. did not perform as well as the benchmark.


SZLS.TO

YTD

0.00%

1M

0.00%

6M

0.00%

1Y

-0.00%

5Y*

-39.33%

10Y*

-40.65%

^GSPC (Benchmark)

YTD

4.01%

1M

1.13%

6M

9.82%

1Y

22.80%

5Y*

12.93%

10Y*

11.26%

*Annualized

Monthly Returns

The table below presents the monthly returns of SZLS.TO, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20250.00%0.00%
2024-0.00%-0.00%-0.00%-20.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-20.00%
202316.67%85.71%-30.77%-11.11%-12.50%-14.29%16.67%-14.29%0.00%-0.00%-16.67%-0.00%-16.67%
2022-20.00%-8.33%-22.73%-35.29%-9.09%-10.00%0.00%0.00%-11.11%0.00%-12.50%-14.29%-80.00%
202137.33%16.50%30.83%-59.24%-14.06%-10.91%-12.24%-2.33%-9.52%-10.53%0.00%-11.76%-60.00%
2020-0.00%0.00%40.00%85.71%-30.77%-33.33%0.00%33.33%26.56%-11.11%-0.00%4.17%87.50%
201940.00%71.43%41.67%-23.53%-38.46%150.00%-30.00%-35.71%-11.11%-0.00%-37.50%-0.00%0.00%
2018-30.43%-31.25%0.00%-18.18%-11.11%0.00%0.00%-25.00%0.00%-16.67%-20.00%25.00%-78.26%
20173.23%15.62%0.00%-18.92%-30.00%-9.52%-26.32%-21.43%-9.09%-20.00%87.50%53.33%-25.81%
20160.00%-33.33%800.00%11.11%-10.00%-5.56%-5.88%25.00%90.00%21.05%-23.91%-11.43%933.33%
2015-17.61%-39.31%-19.32%-50.70%8.57%-7.89%-20.00%-7.14%7.69%-28.57%-80.00%-25.00%-98.30%
2014-11.90%9.46%79.01%-10.34%13.85%-20.27%10.17%3.85%-4.44%39.53%-2.78%0.57%109.52%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of SZLS.TO is 52, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of SZLS.TO is 5252
Overall Rank
The Sharpe Ratio Rank of SZLS.TO is 4646
Sharpe Ratio Rank
The Sortino Ratio Rank of SZLS.TO is 4646
Sortino Ratio Rank
The Omega Ratio Rank of SZLS.TO is 7676
Omega Ratio Rank
The Calmar Ratio Rank of SZLS.TO is 4545
Calmar Ratio Rank
The Martin Ratio Rank of SZLS.TO is 4545
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for StageZero Life Sciences Ltd. (SZLS.TO) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for SZLS.TO, currently valued at 0.00, compared to the broader market-2.000.002.000.001.74
The chart of Sortino ratio for SZLS.TO, currently valued at 0.54, compared to the broader market-4.00-2.000.002.004.006.000.542.36
The chart of Omega ratio for SZLS.TO, currently valued at 1.24, compared to the broader market0.501.001.502.001.241.32
The chart of Calmar ratio for SZLS.TO, currently valued at 0.00, compared to the broader market0.002.004.006.000.002.62
The chart of Martin ratio for SZLS.TO, currently valued at 0.00, compared to the broader market-10.000.0010.0020.0030.000.0010.69
SZLS.TO
^GSPC

The current StageZero Life Sciences Ltd. Sharpe ratio is 0.00. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of StageZero Life Sciences Ltd. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00SeptemberOctoberNovemberDecember2025February0
2.38
SZLS.TO (StageZero Life Sciences Ltd.)
Benchmark (^GSPC)

Dividends

Dividend History


StageZero Life Sciences Ltd. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-99.77%
-0.62%
SZLS.TO (StageZero Life Sciences Ltd.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the StageZero Life Sciences Ltd.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the StageZero Life Sciences Ltd. was 99.77%, occurring on Oct 20, 2023. The portfolio has not yet recovered.

The current StageZero Life Sciences Ltd. drawdown is 99.77%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.77%Apr 11, 20064399Oct 20, 2023
-97.55%Sep 18, 20031Sep 18, 200336Jan 7, 200437
-97.47%Jun 18, 20031Jun 18, 200340Sep 16, 200341
-68.49%May 17, 200226Sep 24, 2002101Jun 16, 2003127
-65.52%Apr 21, 2004351Aug 31, 2005124Feb 28, 2006475

Volatility

Volatility Chart

The current StageZero Life Sciences Ltd. volatility is 0.00%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%1.00%2.00%3.00%4.00%5.00%6.00%SeptemberOctoberNovemberDecember2025February0
3.28%
SZLS.TO (StageZero Life Sciences Ltd.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of StageZero Life Sciences Ltd. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for StageZero Life Sciences Ltd..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab